Latest Communications

07 July 2010
MonoSol Rx Announces FDA Approval of Zuplenz® Oral Soluble Film for Treatment of Nausea and Vomiting

15 June 2010
APR Applied Pharma Research s.a. of Switzerland launches its new corporate website and announces key strategic changes in its Business Model to better compete in the rapidly changing Healthcare industry

09 June 2010
MonoSol Rx and APR Applied Pharma Research s.a. Expand Joint Collaboration Agreement to develop and commercialize film formulations of prescription products


Pharma

Pharmaceutical Global Development

APR IS engaged in the research, development, and licensing of added value, technology driven and clinically proven prescription pharmaceuticals.

The innovative business approach based on an integrated vision of technologies available and market opportunities enables APR to select and in-license innovation opportunities or develop internally the whole cycle of research&development bringing to fruition innovative product deliveries to improve patients quality of life.

APR files and obtains worldwide market approval and sells them through an established network of commercial partners globally.




Search results